Cytek Biosciences, Inc. SEC filings CTKB

Cytek Biosciences, Inc. has 464 filings in SEC EDGAR's recent list, going back to Nov 10, 2020. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.

Cytek Biosciences, Inc. SEC filings
Form Description Filed Period
SD Specialized disclosure (conflict minerals) Jun 1, 2026 —
SD Specialized disclosure (conflict minerals) May 30, 2025 —
SD Specialized disclosure (conflict minerals) May 31, 2024 —
NT 10-K Filing Mar 1, 2024 Dec 31, 2023
NT 10-Q Filing Nov 13, 2023 Sep 30, 2023
EFFECT Filing Jul 22, 2021 —
CERT Filing Jul 21, 2021 —
CORRESP Letter to the SEC Jul 20, 2021 —
8-A12B Filing Jul 19, 2021 —
CORRESP Letter to the SEC Jul 13, 2021 —
UPLOAD Letter from the SEC Jul 12, 2021 —
CORRESP Letter to the SEC Jul 2, 2021 —
UPLOAD Letter from the SEC Jun 28, 2021 —
DRSLTR Filing Jun 14, 2021 —
DRS/A Filing Jun 14, 2021 —
UPLOAD Letter from the SEC May 18, 2021 —
DRS Filing Apr 22, 2021 —
D Filing Nov 10, 2020 —

Showing 18 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Laboratory Analytical Instruments (SIC 3826)
Listed as
CTKB (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Fremont, CA
SEC filer status
Accelerated filer
SEC CIK
1831915

Other Laboratory Analytical Instruments companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.